Amanda Twigg, MD
Associate Professor
Dermatology
School of Medicine

Dr. Raymond specializes in using oral and topical therapies to help reduce the burden of pre-cancerous skin lesions that are common in the immunosuppressed patient population.

Dr. Raymond divides her time between UCSF and the San Francisco Veterans Affairs Health Care System where she attends a complex medical dermatology clinic, surgery clinic, and provides teledermatology services. She is managing a grant from the Office of Rural Health that provides funding to allow San Francisco to serve as a telereading site for other rural VA locations in Northern California and the Pacific Islands.

In addition, Dr. Raymond enjoys clinical teaching and mentoring students and residents. She serves as the UCSF School of Medicine’s Confidential Career Advisor for the Department of Dermatology.

• Treatment of PD-1/PD-L1 Inhibitor-Induced Dermatitis Resolves Concomitant Eruptive Keratoacanthomas.
  JAMA dermatology 2020 Crow LD, Perkins I, Twigg AR, Fassett MS, LeBoit PE, Berger TG, Khodosh R
• Initial skin cancer screening for solid organ transplant recipients in the United States: Delphi method development of expert consensus guidelines.
  Transplant international : official journal of the European Society for Organ Transplantation 2019 Crow LD, Jambusaria-Pahlajani A, Chung CL, Baran DA, Lowenstein SE, Abdelmalek M, Ahmed RL, Anadkat MJ, Arcasoy SM, Berg D, Bibee KP, Billingsley E, Black WH, Blalock TW, Bleicher M, Brennan DC, …
• Cutaneous endometriosis.
  International journal of women's dermatology 2019 Raffi L, Suresh R, McCalmont TH, Twigg AR
• Association of HLA Antigen Mismatch With Risk of Developing Skin Cancer After Solid-Organ Transplant.
  JAMA dermatology 2019 Gao Y, Twigg AR, Hirose R, Roll GR, Nowacki AS, Maytin EV, Vidimos AT, Rajalingam R, Arron ST
• The relationship between menopausal hormone therapy and keratinocyte carcinoma: A review.
  International journal of women's dermatology 2018 Suresh R, Twigg A, Murase JE
• Melanoma Outcomes in Transplant Recipients With Pretransplant Melanoma.
  Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.] 2016 Arron ST, Raymond AK, Yanik EL, Castenson D, McCulloch CE, Clarke CA, Paddock LE, Niu X, Engels EA
• Patterns of recurrence following complete response to regional chemotherapy for in-transit melanoma.
  Annals of surgical oncology 2012 Sharma K, Beasley G, Turley R, Raymond AK, Broadwater G, Peterson B, Mosca P, Tyler D
• Dermatomal sclerodermoid graft-vs-host disease following varicella-zoster virus infection.
  Archives of dermatology 2011 Raymond AK, Singletary HL, Nelson KC, Sidhu-Malik NK
• Current trends in regional therapy for melanoma: lessons learned from 225 regional chemotherapy treatments between 1995 and 2010 at a single institution.
  Journal of the American College of Surgeons 2011 Raymond AK, Beasley GM, Broadwater G, Augustine CK, Padussis JC, Turley R, Peterson B, Seigler H, Pruitt SK, Tyler DS
• Regional treatment strategies for in-transit melanoma metastasis.
  Surgical oncology clinics of North America 2011 Turley RS, Raymond AK, Tyler DS
• A two-hybrid assay to study protein interactions within the secretory pathway.
  PloS one 2010 Dube DH, Li B, Greenblatt EJ, Nimer S, Raymond AK, Kohler JJ
• Regional squamous cell carcinomas following systemic sorafenib therapy and isolated limb infusion for regionally advanced metastatic melanoma of the limb.
  Archives of dermatology 2010 Raymond AK, Puri PK, Selim MA, Tyler DS, Nelson KC